Evidence map›Paper›PMID 35241740›Full record

ArticleScientific reports2022

Prognostic significance of platelet-to-albumin ratio in patients with esophageal squamous cell carcinoma receiving definitive radiotherapy.

Zhiyu Huang, Qunhao Zheng, Yilin Yu, Hongying Zheng, Yahua Wu, Zhiping Wang, Lingyun Liu, Mengyan Zhang, Tianxiu Liu, Hui Li and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Association between metal co-exposure and frailty: exploring the potential explanatory pathway of inflammation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  3. Article
  4. Article
  5. Trajectories of postoperative nutritional risk changes in patients with oesophageal cancer and their relationship with symptom recovery-a multicentre longitudinal study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Zhiyu Huang *Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Qunhao Zheng *Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Yilin YuFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Hongying ZhengFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Yahua WuFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Zhiping WangFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Lingyun LiuFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Mengyan ZhangFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Tianxiu LiuFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Hui LiFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China.
Jiancheng LiFujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, 350014, China. jianchengli_jack@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accumulating evidence indicates that inflammation and nutrition status are associated with clinical outcomes in patients with various malignancies. This study aimed to evaluate the prognostic significance of the pretreatment platelet to albumin ratio (PAR) in esophageal squamous cell carcinoma (ESCC) patients undergoing definitive radiotherapy. A total of 470 patients who underwent definitive radiotherapy with or without chemotherapy were enrolled. The optimal cut-off values of PAR and other indicators were determined by the X-tile. The Kaplan-Meier method, multivariate analyses Cox regression were conducted to identify the association between those indicators and the survival outcomes. The median follow-up time was 23.5 months. The optimal cut-off value of PAR was 5.7 × 10

Indexed as

Esophageal NeoplasmsEsophageal Squamous Cell CarcinomaAlbuminsHumansInflammationLymphocytesNeutrophilsPrognosisProspective StudiesRetrospective StudiesAlbumins

Identifiers

PMID35241740
PMCPMC8894409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.